I have read many of Chris Kallos's MST research reports over the years , and he's always been level headed and pragmatic in his reviews ...
.... but , lest we lose sight of the main issue here : Improving health outcomes for patients .... CYP has achieved a very positive result in a trial to improve the healing of diabetics with foot ulcer wounds ... this is an extremely awesome thing for those folks who are suffering ... which also includes us long time shareholders ...
I have read many of Chris Kallos's MST research reports over the...
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.015(7.14%) |
Mkt cap ! $40.41M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 22.5¢ | 20.0¢ | $96.31K | 448.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15837 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 15037 | 1 |
View Market Depth
| Last trade - 16.10pm 01/05/2024 (20 minute delay) ? |
|
|||||
|
Last
22.0¢ |
Change
0.015 ( 4.76 %) |
||||
| Open | High | Low | Volume | ||
| 20.0¢ | 22.0¢ | 20.0¢ | 56690 | ||
| Last updated 15.55pm 01/05/2024 ? | |||||
| CYP (ASX) Chart |